October 28, 2019 / 1:15 PM / 7 months ago

Allergan settles Alzheimer's therapy lawsuit for $750 million

Oct 28 (Reuters) - Allergan Plc said on Monday it had settled a class action lawsuit brought by a group of direct purchasers of Alzheimer's disease therapy Namenda, resolving the litigation that was set to face trial this month.

Under the agreement, the drugmaker's Forest units will pay $750 million to the plaintiff, which will be recorded as a charge in its third-quarter results.

The company said the settlement makes no admission of wrongdoing on its part.

Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Arun Koyyur

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below